Search research articles
Contact Us
Filters
Showing results (71-80 of 101) with videos related to
Page
of 11
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 24, 2011
Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients
L Licitra, F Perrone, E Tamborini, et al.
Oral Oncology
|
September 23, 2008
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study
L D Locati, P Bossi, F Perrone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 15, 2011
Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer
P Bossi, E Orlandi, C Bergamini, et al.
ESMO Open
|
October 28, 2025
Validation of a prognostic nomogram for locally advanced oropharyngeal carcinoma treated with intensity-modulated radiotherapy with/without systemic therapy
P Bossi, R Gili, S Calza, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 6, 2016
Long-term update of the 24954 EORTC phase III trial on larynx preservation
B Henriques De Figueiredo, C Fortpied, J Menis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 26, 2011
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study
R Granata, R Miceli, E Orlandi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 12, 2018
Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach
R Galot, C Le Tourneau, J Guigay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 7, 2015
Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study
F Roila, B Ruggeri, E Ballatori, et al.
Oral Oncology
|
November 5, 2023
Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease recurrence
K J Harrington, E E W Cohen, D Soulières, et al.
Journal of the National Cancer Institute
|
January 30, 2009
Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy
J L Lefebvre, F Rolland, M Tesselaar, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 101) with videos related to
Sort By:
Page
of 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 24, 2011
Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients
L Licitra, F Perrone, E Tamborini, et al.
Oral Oncology
|
September 23, 2008
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study
L D Locati, P Bossi, F Perrone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 15, 2011
Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer
P Bossi, E Orlandi, C Bergamini, et al.
ESMO Open
|
October 28, 2025
Validation of a prognostic nomogram for locally advanced oropharyngeal carcinoma treated with intensity-modulated radiotherapy with/without systemic therapy
P Bossi, R Gili, S Calza, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 6, 2016
Long-term update of the 24954 EORTC phase III trial on larynx preservation
B Henriques De Figueiredo, C Fortpied, J Menis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 26, 2011
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study
R Granata, R Miceli, E Orlandi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 12, 2018
Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach
R Galot, C Le Tourneau, J Guigay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 7, 2015
Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study
F Roila, B Ruggeri, E Ballatori, et al.
Oral Oncology
|
November 5, 2023
Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease recurrence
K J Harrington, E E W Cohen, D Soulières, et al.
Journal of the National Cancer Institute
|
January 30, 2009
Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy
J L Lefebvre, F Rolland, M Tesselaar, et al.
Page
of 11